In trials, users achieved up to ~24% body-weight reduction over 48 weeks, plus improvements in fat-to-lean mass ratio, insulin sensitivity, and metabolic markers
Semaglutide for weight loss raises an important question for patients and clinicians: how long can you take semaglutide for weight loss
GLP-1 receptor in pancreatic A-cells regulates glucagon secretion in a glucose-dependent bidirectional manner
"With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need." According to Eli Lilly, adults in the Phase 3 trials all lost weight with orforglipron and on the highest dose of 36 mg of orforglipron, the trial participants lost about 27 pounds over the course of 72 weeks or about 12% of their body weight, which is meaningful but not quite as high as some injectables
This isnt speculative
At $149/month self-pay a fraction of Wegovy or Zepbound Foundayo is accessible to patients who can't afford or don't qualify for injectable coverage